Awarded Grants

The ODC offers over 50 grant opportunities in 30+ disease areas annually to researchers across the globe, as well as within the Penn and CHOP communities. Since 2011, our grant programs have funded $17.2 million in rare disease research.

See below for a complete list of ODC-awarded grants since 2011. 

Full list of CDKL5 Program of Excellence Awardees

Awarded Grants

Displaying Results 91 - 100 of 175

Awardee Project Title Institution Grant Amount Funding Year
Michael Kastan, MD, PhD Identification of Therapeutic Interventions in Ataxia-Telangiectasia Using a Novel Model of Metabolic Stress Duke University School of Medicine MDBR - A-T $69,000 2016
Li Changhong, MD, PhD Drug development for treatment of glutamate dehydrogenase hyperinsulinism Children's Hospital of Philadelphia MDBR - CHI $82,000 2016
Stefan Liebau, PhD and Marius Ueffing, PhD Mutated CRB1 in human induced pluripotent stem cell derived retinal organoids Eberhard Karls University Tuebingen, Institute of Neuroanatomy MDBR - CRB1 $50,500 2016
Daniel Marenda, PhD Pharmacological rescue and screening in a Pitt Hopkins model. Drexel University MDBR - Pitt Hopkins $51,000 2016
Eric Marsh, MD, PhD and Tim Benke, MD, PhD Neurophysiological correlates in CDKL5 syndrome: a supplement to the NIH Natural History Study of Rett syndrome, CDKL5 syndrome, and other Rett syndrome-related disorders; protocol RTT5212. Children's Hospital Colorado and Children's Hospital of Philadelphia MDBR - CDKL5 $53,500 2016
Jason Mills, PhD Establishing 3-Dimensional (3D) Retinal Optic Cups using patient-specific CRB1 Induced Pluripotent Stem Cells. University of Pennsylvania MDBR - CRB1 $50,500 2016
Umrao Monani, PhD Exploring the postnatal requirement of the brain for the Glut1 protein Columbia University MDBR - Glut1 $40,000 2016
Charles Nelson, PhD / Michela Fagiolini, PhD / Heather Olson, MD Sensory evoked potentials as a biomarker in CDKL5 Boston Children’s Hospital / Harvard Medical School MDBR - CDKL5 $53,500 2016
Igor Nestrasil, MD MRI signatures of cervical spine alterations in mucopolysaccharidosis type I (MPSI) University of Minnesota MDBR - MPS $52,000 2016
Suneet Agarwal, MD, PhD A multi-center, prospective, minimal intensity BMT trial for dyskeratosis congenita Boston Children's Hospital MDBR - DC $51,000 2016
1 8 9 10 11 12 18